INMD News and Press, InMode Ltd. From 07/26/23

2023-07-26 12:32:19 ET InMode ( NASDAQ: INMD ) is scheduled to announce Q2 earnings results on Thursday, July 27th, before market open. The consensus EPS Estimate is $0.66 (+11.9% Y/Y) and the consensus Revenue Estimate is $132.55M (+16.7% Y/Y). Over the last 2 years, ...

InMode Expands Women's Health and Wellness Market Footprint through Acquisition of Viveve Patents PR Newswire YOKNEAM, Israel , July 25, 2023 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) (" InMode "), a leading global provider of innovative medical technol...

2023-07-18 10:59:50 ET Summary I discuss the investment potential of InMode, a company specializing in laser equipment for aesthetic medicine treatments, which has seen significant growth and offers high growth prospects with attractive profit margins. My analysis of InMode's busi...

2023-07-12 16:40:00 ET Shares of cosmetic medical device company InMode (NASDAQ: INMD) flew to new 52-week highs on Wednesday after the company released preliminary financial results for the second quarter of 2023 and raised its guidance for the year. As of 3:15 p.m. ET, InMode stoc...

2023-07-12 07:08:35 ET InMode ( NASDAQ: INMD ) reports Q2 revenue of $135.7 million to $135.9M vs. $130.26M consensus, Non-GAAP EPS of $0.70 to $0.71 vs. $0.64 consensus. Q2 Non-GAAP gross margin will be in the range of 83% to 85%. The company has ...

InMode Expects Second Quarter 2023 Revenue Between $135.7-$135.9M, Increases Full Year 2023 Guidance, Expects Revenues of $530-540M PR Newswire Conference call to be held on Thursday, July 27, 2023, at 8:30 a.m. Eastern Time YOKNEAM, Israel , July 12, 2...

2023-07-11 09:00:00 ET Summary InMode's valuations have been discounted drastically compared to its 3Y means and its peers, suggesting its overly depressed price target of $48.30. However, we believe an upward revision to P/E of 18x is warranted, suggesting a more optimistic long-...

2023-07-10 10:00:00 ET With market capitalizations ranging from $3.6 billion to $7.2 billion, these four mid-cap stocks offer multi-bagger potential. Doximity (NYSE: DOCS) and Progyny (NASDAQ: PGNY) are home to first-mover advantages -- giving them a head start over their co...

2023-06-26 07:59:40 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Buying and holding stocks for the long term takes up less time and can produce solid returns. Instead of looking at technical indicators and studying the market every day, investors can focus...

2023-06-14 14:36:53 ET InMode ( NASDAQ: INMD ) ticked up 0.5% amid a positive mention from an investor about the aesthetics company. InMode ( INMD ) was pitched by Aureus Asset Management's Karen Firestone as a "final trade" on CNBC's "Halftime" show. "There are a...